Artificial intelligence in neurocritical care
Artificial intelligence (AI) has been introduced into medicine and an AI-assisted medicine will be the future that we should help to shape. In particular, supervised, unsupervised, and reinforcement learning will be the main methods to play a role in the implementation of AI. Severely ill patients admitted to the intensive care unit (ICU) are closely monitored in order to be able to quickly respond to any changes. These monitoring data can be used to train AI models to predict critical phases in advance, making an earlier reaction possible. To achieve this a large amount of clinical data are needed in order to train models and an external validation on independent cohorts should take place. Prospective studies with treatment of patients admitted to the ICU with AI assistance should show that they provide a benefit for patients. We present the most important resources from de-identified (anonymized) patient data on open-source use for AI research in intensive care medicine. The focus is on neurological diseases in the ICU, therefore, we provide an overview of existing models for prediction of outcome, vasospasms, intracranial pressure and levels of consciousness. To introduce the advantages of AI in the clinical routine, more AI-based models with larger datasets will be needed. To achieve this international cooperation is absolutely necessary. Clinical centers associated with universities are needed to provide a constant validation of applied models as these models can change during use or a bias can develop during the training. A strong commitment to AI research is important for Germany, not only with respect to academic achievements but also in the light of a rapidly growing influence of AI on the economy.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:92 |
|---|---|
| Enthalten in: |
Der Nervenarzt - 92(2021), 2 vom: 25. Feb., Seite 115-126 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
Künstliche Intelligenz in der Neurointensivmedizin |
|---|
| Beteiligte Personen: |
Schweingruber, N [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Coma |
|---|
| Anmerkungen: |
Date Completed 11.02.2021 Date Revised 10.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00115-020-01050-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320532402 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320532402 | ||
| 003 | DE-627 | ||
| 005 | 20231225173801.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00115-020-01050-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1068.xml |
| 035 | |a (DE-627)NLM320532402 | ||
| 035 | |a (NLM)33491152 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Schweingruber, N |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Artificial intelligence in neurocritical care |
| 246 | 3 | 3 | |a Künstliche Intelligenz in der Neurointensivmedizin |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.02.2021 | ||
| 500 | |a Date Revised 10.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Artificial intelligence (AI) has been introduced into medicine and an AI-assisted medicine will be the future that we should help to shape. In particular, supervised, unsupervised, and reinforcement learning will be the main methods to play a role in the implementation of AI. Severely ill patients admitted to the intensive care unit (ICU) are closely monitored in order to be able to quickly respond to any changes. These monitoring data can be used to train AI models to predict critical phases in advance, making an earlier reaction possible. To achieve this a large amount of clinical data are needed in order to train models and an external validation on independent cohorts should take place. Prospective studies with treatment of patients admitted to the ICU with AI assistance should show that they provide a benefit for patients. We present the most important resources from de-identified (anonymized) patient data on open-source use for AI research in intensive care medicine. The focus is on neurological diseases in the ICU, therefore, we provide an overview of existing models for prediction of outcome, vasospasms, intracranial pressure and levels of consciousness. To introduce the advantages of AI in the clinical routine, more AI-based models with larger datasets will be needed. To achieve this international cooperation is absolutely necessary. Clinical centers associated with universities are needed to provide a constant validation of applied models as these models can change during use or a bias can develop during the training. A strong commitment to AI research is important for Germany, not only with respect to academic achievements but also in the light of a rapidly growing influence of AI on the economy | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Coma | |
| 650 | 4 | |a Machine learning | |
| 650 | 4 | |a Neurology | |
| 650 | 4 | |a Sedation | |
| 650 | 4 | |a Stroke | |
| 700 | 1 | |a Gerloff, C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Der Nervenarzt |d 1947 |g 92(2021), 2 vom: 25. Feb., Seite 115-126 |w (DE-627)NLM000034320 |x 1433-0407 |7 nnns |
| 773 | 1 | 8 | |g volume:92 |g year:2021 |g number:2 |g day:25 |g month:02 |g pages:115-126 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00115-020-01050-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 92 |j 2021 |e 2 |b 25 |c 02 |h 115-126 | ||